Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

COVID 19 vaccine - Gamaleya National Research Center of Epidemiology and Microbiology

X
Drug Profile

COVID 19 vaccine - Gamaleya National Research Center of Epidemiology and Microbiology

Alternative Names: COVID-2019 vaccine - Gamaleya National Research Center of Epidemiology and Microbiology; Gam COVID Vak; Gam-COVID-Vac; single-dose Sputnik Light vaccine; Sputnik M; Sputnik V; Sputnik V vaccine; Sputnik-Light V vaccine

Latest Information Update: 28 Aug 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Gamaleya Research Institute of Epidemiology and Microbiology
  • Developer AstraZeneca; Dr Reddys Laboratories; Gamaleya Research Institute of Epidemiology and Microbiology; Pure Health; R-Pharm; The Government of Serbia
  • Class COVID-19 vaccines; Synthetic vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered COVID 2019 infections

Most Recent Events

  • 28 Aug 2024 No recent reports of development identified for clinical-Phase-Unknown development in COVID-2019-infections(Combination therapy, In the elderly, Prevention, In adults) in United Arab Emirates (IM, Injection)
  • 05 Oct 2023 Gamaleya Research Institute of Epidemiology and Microbiology plans phase III trial for COVID 2019 infections (Prevention, In children, In adolescents ) in October 2023 (IM) (NCT06068556)
  • 05 Oct 2023 Gamaleya Research Institute of Epidemiology and Microbiology plans phase-III trial for COVID-2019 infection (prevention) in September 2023 (IM, Injection) (NCT06057025)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top